LFST Stock Analysis: Buy, Sell, or Hold?
LFST - LifeStance Health Group, Inc. Common Stock
$7.89
-0.21 (-2.59%)
▼
5d:
-10.85%
30d:
+20.46%
90d:
+14.02%
WAIT
LOW Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When LFST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LFST is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LFST is down 10.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.94
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.14
29.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 23.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFST is currently trading at $7.89, which is considered extended relative to its 30-day fair value range of $6.55 to $7.76. From a valuation perspective, the stock is trading at a discount (Forward PE: 20.0) compared to its historical average (23.3). Remarkably, the market is currently pricing in an annual earnings decline of 5.0% over the next few years. This pessimistic expectation contrasts with the company's recent 1927.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, LFST is in a downtrend. Immediate support is located at $7.17, while resistance sits at $8.89.
Market Sentiment: LFST has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.61 (+34.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LFST is in a downtrend. Immediate support is located at $7.17, while resistance sits at $8.89.
Market Sentiment: LFST has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $10.61 (+34.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$6.55 -
$7.76
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 34.5% below Wall St target ($10.61)
- WARNING: Recommendation downgraded due to -10.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$6.55 -
$7.76
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.18
Resistance Level
$8.89
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.96
Wall Street Target
$10.61
(+34.5%)
Revenue Growth (YoY)
21.2%
Earnings Growth (YoY)
1927.5%
Profit Margin
1.6%
Valuation Discount vs History
-5.0% cheaper
PE vs Historical
20.0 vs 23.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.0%
(market-implied from PE analysis)
1-Year Target
$7.50
(-5%)
2-Year Target
$7.12
(-10%)
3-Year Target
$6.76
(-14%)
3-Yr Target (if PE normalizes)
(PE: 20→23)
$7.90
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 25.3%)
$17.15
(+117%)
Base:
(SPY PE: 20.0, Growth: 25.3%)
$15.53
(+97%)
Bear:
(PE: 17.0, Growth: 25.3%)
$13.20
(+67%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (77x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Forward PE: 76.92 | Forward EPS (Implied): $0.10
Bull Case
$9.53
(+21%)
Analyst growth 15.0%, PE expands to 80.8
Base Case
$7.89
(0%)
Market implied 0.0%, PE stable at 76.9
Bear Case
$6.04
(-24%)
Severe decline -15.0%, PE contracts to 69.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.0 to 23.3
Stabilization Target:
$9.21
(+16.7%)
PE Expansion Potential:
+16.7%
Share & Embed Analysis
Last updated: May 15, 2026 8:57 AM ET
Data refreshes hourly during market hours. Next update: 9:57 AM
Data refreshes hourly during market hours. Next update: 9:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Robert Bessler
SELL
5101 shares
2026-04-21
Darren M Black
SELL
4314939 shares
2026-03-02
Robert Bessler
SELL
1701 shares
2025-12-22
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
